Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome
- 23 May 2013
- journal article
- case report
- Published by Springer Nature in Pediatric Nephrology
- Vol. 28 (9) , 1875-1879
Abstract
We report a 7-year-old boy with high-degree steroid-dependent idiopathic nephrotic syndrome (SDNS) who went into remission with rituximab (RTX) maintenance therapy. Four months after this patient received his first RTX infusion, there was a progressive and sustained decrease of immunoglobulin (Ig)G and IgM levels. Thirteen months after the initiation of RTX therapy he was in sustained remission without any steroid or oral immunosuppressive therapy; however, B cell depletion was still present. At this time he developed a fulminant myocarditis due to enterovirus. Despite aggressive treatment and the administration of intravenous polyvalent immunoglobulins there was no clinical improvement. He successfully underwent heart transplant surgery. We conclude that B cell depletion with RTX is efficacious in the treatment of paediatric SDNS but that it may be associated with severe infectious complications. Therefore, we recommend a close monitoring of Ig levels in children who have received RTX therapy and a supplementation with intravenous Ig as soon as the Ig levels fall below the lower limit of the normal rangeKeywords
This publication has 26 references indexed in Scilit:
- Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndromePediatric Nephrology, 2012
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated VasculitidesPLOS ONE, 2012
- Use of Intravenous Immunoglobulin Compared With Standard Therapy is Associated With Improved Clinical Outcomes in Children With Acute Encephalitis Syndrome Complicated by MyocarditisPediatric Cardiology, 2012
- Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndromeNephrology Dialysis Transplantation, 2011
- Rituximab efficiency in children with steroid-dependent nephrotic syndromePediatric Nephrology, 2010
- Severe respiratory adverse events associated with rituximab infusionPediatric Nephrology, 2009
- Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in childrenPediatric Nephrology, 2009
- Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent LymphomaCancer Investigation, 2008
- Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapseArthritis & Rheumatism, 2006
- Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post‐transplant EBV‐associated autoimmune hemolytic anemiaEuropean Journal of Haematology, 2005